"Designing Growth Strategies is in our DNA"

Canada Human Fibrinogen Concentrates Market Size, Share & Industry Analysis, By Product (Fibryga, RiaSTAP, and Others), By Application (Congenital Fibrinogen Deficiency, Acquired Fibrinogen Deficiency & Surgical Procedures, and Others), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Forecasts, 2025-2032

Last Updated: December 30, 2025 | Format: PDF | Report ID: FBI114979

 


To get information on various segments, share your queries with us

ATRRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 8.12% from 2025-2032
Unit Value (USD Million)
Segmentation By Product, Application, End User, and Country
By Product 
  • Fibryga
  • RiaSTAP
  • Others
By Application
  • Congenital Fibrinogen Deficiency
  • Acquired Fibrinogen Deficiency & Surgical Procedures
  • Others
By End User
  • Hospitals & ASCs
  • Specialty Clinics
  • Others 

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 100
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann